Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News SQZ Biotechnologies Company (EM) SQZB

Healthcare Biotechnology
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (EXPM:SQZB)

Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider

GlobeNewswire May 6, 2024

Asset Sale and Plan of Liquidation and Dissolution Approved by SQZB Shareholders

Business Wire February 29, 2024

SQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio Updates

Business Wire November 8, 2023

SQZ Biotechnologies Reports Data for Clinical Programs at the Society for Immunotherapy of Cancer Annual Meeting

Business Wire November 3, 2023

SQZ Biotechnologies Reports Second Quarter 2023 Financial Results and Recent Portfolio Updates

Business Wire August 10, 2023

SQZ Biotechnologies Provides Update on Collaboration with Roche

Business Wire July 25, 2023

SQZ Biotechnologies to Consolidate Shares with 1-for-10 Reverse Stock Split

Business Wire June 15, 2023

SQZ Biotechnologies Reports First Quarter 2023 Financial Results and Recent Portfolio Updates

Business Wire May 10, 2023

SQZ Biotechnologies Announces Confirmed Complete Response in HPV16+ Solid Tumor Patient in the Lowest-Dose Cohort of the SQZ-AAC-HPV-101 Clinical Trial

Business Wire March 22, 2023
View More News ››

Opinion & Analysis (EXPM:SQZB)

No current opinion is available.
View More Opinion ››

Bullboard Posts (EXPM:SQZB)

Weird!

For three days now SQZ has traded modest volume with the price at $8 and flat as a board on the modest news of a publication. What gives...
zalmonella - February 2, 2022
View more Bullboard ››

AE Fuels Corporation

AE Fuels Corporation

AE Fuels Corporation (TSXV: AEF) is a battery materials company focused on the extraction and purification of minerals ...
View More »

Podcasts